Nova Mentis Life Science (TSE:NOVA) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nova Mentis Life Science Corp. appoints Steve Loutskou as the new President and CEO, aiming to drive future growth with his extensive entrepreneurial experience. This leadership change follows the resignation of William Rascan, who significantly contributed to the company’s development, including securing an orphan drug designation for psilocybin treatment.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.